Showing all 2 results

    • Pluslife

      $4.99

      This kit is used for in vitro qualitative detection of SARS-CoV-2 and Influenza A, Influenza B in human nasal swab samples.

      The assay is based on isothermal amplification method and enzyme digestion probe technology, and conserved regions are selected for specific primers and specific probes design. A large number of target sequence’s copies were generated in the reaction system during the isothermal amplification. When the probe hybridizes to the complementary sequence, it is cleaved, and fluorescence is emitted. Integrated Nucleic Acid Testing Device detects and analyzes fluorescence signal automatically, reporting negative, positive or invalid result. The assay includes internal control for monitoring of sample collection, processing, and amplification to reduce false negative results.

      1. Technical introduction
      1.1 Microfluidics technology: Microfluidics refers to the science and technology involved in systems that microtubes (tens to hundreds of micrometers in size) to process or manipulate tiny volumes of fluids (ranging from nanoliters to attoliters). It is an emerging interdisciplinary discipline involving chemistry, fluid physics, microelectronics, new materials, biology, and biomedical engineering. Because of the characteristics of miniaturization and integration, microfluidic devices are commonly referred to as microfluidic chips, and also known as lab-on-a-chip devices and micro total analysis systems. 1.2 Isothermal nucleic acid amplification technology: this is the general term for a class of molecular biology technology that expands the copy number of a particular DNA or RNA fragment at a particular temperature. At present, the main isothermal amplification technologies include rolling circle nucleic acid amplification, loop-mediated is temperature amplification, strand displacement amplification, nucleic acid sequence-based amplification and helicase-dependent amplification. They all share common characteristics: constant temperature, high efficiency, special, no need for special

      2. Main uses and scope of application
      It can be used with adaptive microfluidic chips for in vitro amplification detection of sample nucleic acid.

    • Boson

      $4.99

      The Rapid COVID Antigen Test Card is a lateral flow immunoassay intended for the qualitative detection of nucleocapsid protein antigen from SARS-CoV-2. This test is authorized for non-prescription home use with self-collected anterior nasal swab samples from individuals aged 14 years or older when tested twice over three days with at least 24 hours (and no more than 48 hours) between tests. The test is authorized for individuals with symptoms of COVID-19 within the first 6 days of symptom onset, or without symptoms or other epidemiological reasons to suspect COVID-19.

      This test is also authorized for non-prescription home use with adult-collected anterior nasal swab samples from individuals aged 2 years or older when tested twice over three days with at least 24 hours between tests. The test is authorized for individuals aged 2 years and older with symptoms of COVID-19 within the first 6 days of symptom onset, or individuals without symptoms or other epidemiological reasons to suspect COVID-19.

      CLINICAL FEATURES
      The performance of the Rapid SARS-CoV-2 Antigen Test Card was established in a prospective clinical study of symptomatic individuals using an EUA molecular test as a comparator method. The data from this study were analyzed using the minimum recommended number of low positives demonstrating that the test correctly identified 82.7% of positive samples and correctly identified 99.1% of negative samples.

    Start typing and press Enter to search

    Shopping Cart
    No products in the cart.